These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34425054)

  • 21. Predicted critical environmental concentrations for 500 pharmaceuticals.
    Fick J; Lindberg RH; Tysklind M; Larsson DG
    Regul Toxicol Pharmacol; 2010 Dec; 58(3):516-23. PubMed ID: 20816909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aquatic plants exposed to pharmaceuticals: effects and risks.
    Brain RA; Hanson ML; Solomon KR; Brooks BW
    Rev Environ Contam Toxicol; 2008; 192():67-115. PubMed ID: 18020304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human pharmaceuticals in the marine environment: Focus on exposure and biological effects in animal species.
    Fabbri E; Franzellitti S
    Environ Toxicol Chem; 2016 Apr; 35(4):799-812. PubMed ID: 26111460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioaccumulation and biomagnification potential of pharmaceuticals with a focus to the aquatic environment.
    Zenker A; Cicero MR; Prestinaci F; Bottoni P; Carere M
    J Environ Manage; 2014 Jan; 133():378-87. PubMed ID: 24419205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human pharmaceuticals in marine mussels: Evidence of sneaky environmental hazard along Italian coasts.
    Mezzelani M; Fattorini D; Gorbi S; Nigro M; Regoli F
    Mar Environ Res; 2020 Dec; 162():105137. PubMed ID: 33010617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxicities of 48 pharmaceuticals and their freshwater and marine environmental assessment in northwestern France.
    Minguez L; Pedelucq J; Farcy E; Ballandonne C; Budzinski H; Halm-Lemeille MP
    Environ Sci Pollut Res Int; 2016 Mar; 23(6):4992-5001. PubMed ID: 25292303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occurrence, distribution, and ecotoxicological risk assessment of selected pharmaceutical compounds in water from Lake Victoria, Uganda.
    Nantaba F; Wasswa J; Kylin H; Palm WU; Bouwman H; Kümmerer K
    Chemosphere; 2020 Jan; 239():124642. PubMed ID: 31521936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmaceuticals in two watersheds in Eastern China and their ecological risks.
    Tang J; Sun J; Wang W; Yang L; Xu Y
    Environ Pollut; 2021 May; 277():116773. PubMed ID: 33640818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A rational approach to selecting and ranking some pharmaceuticals of concern for the aquatic environment and their relative importance compared with other chemicals.
    Donnachie RL; Johnson AC; Sumpter JP
    Environ Toxicol Chem; 2016 Apr; 35(4):1021-7. PubMed ID: 26184376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occurrence, fate and effects of azoxystrobin in aquatic ecosystems: a review.
    Rodrigues ET; Lopes I; Pardal MÂ
    Environ Int; 2013 Mar; 53():18-28. PubMed ID: 23314040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring pharmaceuticals in the aquatic environment using enzyme-linked immunosorbent assay (ELISA)-a practical overview.
    Jaria G; Calisto V; Otero M; Esteves VI
    Anal Bioanal Chem; 2020 Jul; 412(17):3983-4008. PubMed ID: 32088755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The antineoplastic drugs cyclophosphamide and cisplatin in the aquatic environment - Review.
    Queirós V; Azeiteiro UM; Soares AMVM; Freitas R
    J Hazard Mater; 2021 Jun; 412():125028. PubMed ID: 33951853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Critical review: Grand challenges in assessing the adverse effects of contaminants of emerging concern on aquatic food webs.
    Nilsen E; Smalling KL; Ahrens L; Gros M; Miglioranza KSB; Picó Y; Schoenfuss HL
    Environ Toxicol Chem; 2019 Jan; 38(1):46-60. PubMed ID: 30294805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ecotoxicological potential of non-steroidal anti-inflammatory drugs (NSAIDs) in marine organisms: Bioavailability, biomarkers and natural occurrence in Mytilus galloprovincialis.
    Mezzelani M; Gorbi S; Da Ros Z; Fattorini D; d'Errico G; Milan M; Bargelloni L; Regoli F
    Mar Environ Res; 2016 Oct; 121():31-9. PubMed ID: 27036085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ecotoxicology of human pharmaceuticals.
    Fent K; Weston AA; Caminada D
    Aquat Toxicol; 2006 Feb; 76(2):122-59. PubMed ID: 16257063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single and mixture toxicity of four pharmaceuticals of environmental concern to aquatic organisms, including a behavioral assessment.
    Godoy AA; Oliveira ÁC; Silva JGM; Azevedo CCJ; Domingues I; Nogueira AJA; Kummrow F
    Chemosphere; 2019 Nov; 235():373-382. PubMed ID: 31271997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxicity assessment of five emerging pollutants, alone and in binary or ternary mixtures, towards three aquatic organisms.
    Di Poi C; Costil K; Bouchart V; Halm-Lemeille MP
    Environ Sci Pollut Res Int; 2018 Mar; 25(7):6122-6134. PubMed ID: 28620858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transformation products of pharmaceuticals in the environment: Their fate, (eco)toxicity and bioaccumulation potential.
    Maculewicz J; Kowalska D; Świacka K; Toński M; Stepnowski P; Białk-Bielińska A; Dołżonek J
    Sci Total Environ; 2022 Jan; 802():149916. PubMed ID: 34525754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colloids as a sink for certain pharmaceuticals in the aquatic environment.
    Maskaoui K; Zhou JL
    Environ Sci Pollut Res Int; 2010 May; 17(4):898-907. PubMed ID: 20024675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmaceuticals in the environment in Italy: causes, occurrence, effects and control.
    Zuccato E; Castiglioni S; Fanelli R; Reitano G; Bagnati R; Chiabrando C; Pomati F; Rossetti C; Calamari D
    Environ Sci Pollut Res Int; 2006 Jan; 13(1):15-21. PubMed ID: 16417127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.